Awakn Life Sciences Receives Regulatory and Ethical Approval for Phase III Clinical Trial of AWKN-P001 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Your plan is not working : Braverman lashes out at UK PM Sunak day after her sacking webindia123.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webindia123.com Daily Mail and Mail on Sunday newspapers.
Former UK Home Secretary Suella Braverman launched a scathing attack on British Prime Minister Rishi Sunak, accusing him of failing to fulfill his promises on key issues such as illegal immigration and rising anti-Semitism. Braverman, who was recently sacked by Sunak, took to social media to express her disappointment. She claimed that she had accepted the position on the condition that certain policy priorities would be addressed, but Sunak had failed to deliver on any of them. Braverman also criticized Sunak s response to the recent pro-Palestine rallies in the UK, calling it weak and lacking in leadership.
Your Plan Is Not Working : Ousted Home Secretary Suella Braverman Lashes Out At Rishi Sunak In Letter To UK PM Day After Her Sacking freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.
The U.K. Medicines and Healthcare Regulatory Agency (MHRA) has green-lighted two separate Phase 3 trials conducted by Compass Pathways (NASDAQ: CMPS) for Treatment-Resistant Depression and Awakn Life Sciences (OTCMKTS: AWKNF) for Severe Alcohol Use Disorder (SAUD).